These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22892212)

  • 1. Synthesis of paclitaxel-BGL conjugates.
    Nemoto H; Katagiri A; Kamiya M; Kawamura T; Matsushita T; Matsumura K; Itou T; Hattori H; Tamaki M; Ishizawa K; Miyamoto L; Abe S; Tsuchiya K
    Bioorg Med Chem; 2012 Sep; 20(18):5559-67. PubMed ID: 22892212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting by covalent conjugation of a natural fatty acid to paclitaxel.
    Bradley MO; Webb NL; Anthony FH; Devanesan P; Witman PA; Hemamalini S; Chander MC; Baker SD; He L; Horwitz SB; Swindell CS
    Clin Cancer Res; 2001 Oct; 7(10):3229-38. PubMed ID: 11595719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
    Jang MK; Jeong YI; Nah JW
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of water-soluble morpholino-decorated paclitaxel prodrugs with remarkably decreased toxicity.
    Feng S; Chen K; Wang C; Jiang X; Dong H; Gong Z; Liu K
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3598-602. PubMed ID: 27311893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses and antitumor activities of N'1,N'3-dialkyl-N'1,N'3-di-(alkylcarbonothioyl) malonohydrazide: the discovery of elesclomol.
    Chen S; Sun L; Koya K; Tatsuta N; Xia Z; Korbut T; Du Z; Wu J; Liang G; Jiang J; Ono M; Zhou D; Sonderfan A
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5070-6. PubMed ID: 23937981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
    Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
    J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications.
    Chun C; Lee SM; Kim SY; Yang HK; Song SC
    Biomaterials; 2009 Apr; 30(12):2349-60. PubMed ID: 19178941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
    Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
    J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
    Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 2-acyl analogues of paclitaxel (Taxol).
    Kingston DG; Chaudhary AG; Chordia MD; Gharpure M; Gunatilaka AA; Higgs PI; Rimoldi JM; Samala L; Jagtap PG; Giannakakou P; Jiang YQ; Lin CM; Hamel E; Long BH; Fairchild CR; Johnston KA
    J Med Chem; 1998 Sep; 41(19):3715-26. PubMed ID: 9733497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
    Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.
    Jang YL; Yun UJ; Lee MS; Kim MG; Son S; Lee K; Chae SY; Lim DW; Kim HT; Kim SH; Jeong JH
    Int J Pharm; 2012 Sep; 434(1-2):488-93. PubMed ID: 22613208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, modeling, and anti-tubulin activity of a D-seco paclitaxel analogue.
    Barboni L; Giarlo G; Ricciutelli M; Ballini R; Georg GI; VanderVelde DG; Himes RH; Wang M; Lakdawala A; Snyder JP
    Org Lett; 2004 Feb; 6(4):461-4. PubMed ID: 14961598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity.
    Guillemard V; Saragovi HU
    Cancer Res; 2001 Jan; 61(2):694-9. PubMed ID: 11212270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel conjugation with the analog of the gonadotropin-releasing hormone as a targeting moiety.
    Pribylova M; Dvorakova M; Hanusova V; Nemethova I; Skalova L; Vanek T
    Int J Pharm; 2011 Aug; 415(1-2):175-80. PubMed ID: 21669266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
    Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
    J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel.
    Desai N; Trieu V; Yao Z; Louie L; Ci S; Yang A; Tao C; De T; Beals B; Dykes D; Noker P; Yao R; Labao E; Hawkins M; Soon-Shiong P
    Clin Cancer Res; 2006 Feb; 12(4):1317-24. PubMed ID: 16489089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway.
    Tian HL; Yu T; Xu NN; Feng C; Zhou LY; Luo HW; Chang DC; Le XF; Luo KQ
    Cancer Lett; 2010 Nov; 297(1):18-30. PubMed ID: 20494511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics.
    Haider S; Penfornis P; Claudio PP; McChesney JD; Chittiboyina AG
    Eur J Med Chem; 2022 Jan; 227():113891. PubMed ID: 34656042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.